Purple glove syndrome: Difference between revisions

No edit summary
 
(5 intermediate revisions by 4 users not shown)
Line 2: Line 2:
*Uncommon skin complication of [[phenytoin]]
*Uncommon skin complication of [[phenytoin]]
*Typically associated with IV infiltration of phenytoin, but poorly understood pathophysiology
*Typically associated with IV infiltration of phenytoin, but poorly understood pathophysiology
**Proposed mechanisms include: <ref>Bhattacharjee P.. Early histopathologic changes in purple glove syndrome. J Cutan Pathol. 2004;31(7):513-5.</ref>
*Proposed mechanisms include:<ref>Bhattacharjee P.. Early histopathologic changes in purple glove syndrome. J Cutan Pathol. 2004;31(7):513-5.</ref>
***chemical irritation from added propylene glycol and sodium hydroxide
**Chemical irritation from added propylene glycol and sodium hydroxide
***vasoconstriction
**Vasoconstriction
***vasculitis
**Vasculitis
***microthrombus formation
**Microthrombus formation
*** phenytoin leakage into soft tissue with subsequent edema  
**Phenytoin leakage into soft tissue with subsequent edema  
*Generally develops within first 24 hours after infusion, resolves within days to weeks <ref> Santoshi JA. Purple glove syndrome: a case report. Hand surgeons and physicians be aware. J Plast Reconstr Aesthet Surg. 2010;63(3):e340-2.</ref>
*Generally develops within first 24 hours after infusion, resolves within days to weeks <ref> Santoshi JA. Purple glove syndrome: a case report. Hand surgeons and physicians be aware. J Plast Reconstr Aesthet Surg. 2010;63(3):e340-2.</ref>


[[File:Purple_glove_syndrome.png|thumb|]]
[[File:Purple_glove_syndrome.png|thumb|]]


==Clinical Features==
==Clinical Features==
Line 19: Line 18:


==Differential Diagnosis==
==Differential Diagnosis==
*Simple IV fluid extravasation
*[[Arterial thrombosis]]
*[[Compartment syndrome]]
{{SSTI DDX}}


==Evaluation==
==Evaluation==
*Clinical diagnosis based on history and exam
*Clinical diagnosis based on history and exam
==Management==
==Management==
*Optimal management remains unclear
*Optimal management remains unclear
*Some case reports found improvement with  
*Some case reports found improvement with  
**topical nitroglycerin
**topical [[nitroglycerin]]
** brachial plexus nerve block
**brachial plexus nerve block
**elevation, heat application, soft tissue massage
**elevation, heat application, soft tissue massage
*Consider vascular or hand consult if digital or skin necrosis suspected
*Consider vascular or hand consult if digital or skin necrosis suspected
**Anticoagulation is occasionally started (no clear evidence that it is effective) <ref>Scumpia AJ. Purple glove syndrome after intravenous phenytoin administration presenting in the emergency department. J Emerg Med. 2013;44(2):e281-3.</ref>
**Anticoagulation is occasionally started (no clear evidence that it is effective) <ref>Scumpia AJ. Purple glove syndrome after intravenous phenytoin administration presenting in the emergency department. J Emerg Med. 2013;44(2):e281-3.</ref>
==Disposition==
==Disposition==
*Given possibility of severe outcomes, recommend 24 hours of observation in asymptomatic patients
*Given possibility of severe outcomes, recommend 24 hours of observation in asymptomatic patients
Line 39: Line 45:


==External Links==
==External Links==


==References==
==References==
<references/>
<references/>


[[Category:Toxicology]] [[Category:Dermatology]]
[[Category:Toxicology]]
[[Category:Dermatology]]

Latest revision as of 03:53, 8 March 2021

Background

  • Uncommon skin complication of phenytoin
  • Typically associated with IV infiltration of phenytoin, but poorly understood pathophysiology
  • Proposed mechanisms include:[1]
    • Chemical irritation from added propylene glycol and sodium hydroxide
    • Vasoconstriction
    • Vasculitis
    • Microthrombus formation
    • Phenytoin leakage into soft tissue with subsequent edema
  • Generally develops within first 24 hours after infusion, resolves within days to weeks [2]
Purple glove syndrome.png

Clinical Features

  • Peripheral edema, blistering, pain, and discoloration of the extremity receiving intravenous phenytoin
  • Pulses and sensation may be diminished
  • Skin necrosis may develop

Differential Diagnosis

Skin and Soft Tissue Infection

Look-A-Likes

Evaluation

  • Clinical diagnosis based on history and exam

Management

  • Optimal management remains unclear
  • Some case reports found improvement with
    • topical nitroglycerin
    • brachial plexus nerve block
    • elevation, heat application, soft tissue massage
  • Consider vascular or hand consult if digital or skin necrosis suspected
    • Anticoagulation is occasionally started (no clear evidence that it is effective) [3]

Disposition

  • Given possibility of severe outcomes, recommend 24 hours of observation in asymptomatic patients

See Also

External Links

References

  1. Bhattacharjee P.. Early histopathologic changes in purple glove syndrome. J Cutan Pathol. 2004;31(7):513-5.
  2. Santoshi JA. Purple glove syndrome: a case report. Hand surgeons and physicians be aware. J Plast Reconstr Aesthet Surg. 2010;63(3):e340-2.
  3. Scumpia AJ. Purple glove syndrome after intravenous phenytoin administration presenting in the emergency department. J Emerg Med. 2013;44(2):e281-3.